This browser is not actively supported anymore. For the best passle experience, we strongly recommend you upgrade your browser.

BioTalk

3 results for: dusseldorf

1/30/2026 11:21:12 AM

EDPB Reconsiders Anonymisation and Pseudonymisation After SRB: What Life Sciences Organisations Need to Know

By Wilfred Steenbruggen

1. Introduction On 12 December 2025, the European Data Protection Board (EDPB) hosted a focused stakeholder event to gather input for...

12/2/2025 4:16:31 PM

By Andreas Obermeier Anna Wolters-Höhne Phoebe Greybanks

Recent German court decisions have fundamentally shifted the risk landscape for generic and biosimilar companies facing second medical...

10/27/2025 11:54:53 AM

By Pieter Erasmus Maud van Haaren Hester Borgers

The EU regulatory landscape for medical devices making use of artificial intelligence (MDAI) has become significantly more complex with...